Learn how ulcerative colitis affects your chances of getting the common cold or flu, and what you can do to treat or prevent ...

Absci is developing ABS-101, an anti-TL1A antibody with potential in ulcerative colitis, Crohn's disease, and other ...

Common medications used to treat ulcerative colitis, such as 5-aminosalycates, biologics, steroids, and JAK inhibitors, can cause unwanted side effects.

Years ago, St-Pierre said he was out in Montreal when he came across the man who bullied him as a child, washing windows and ...

Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...

This came after the firm presented their proposal for a grant of permission to conduct an Active Post Marketing Surveillance ...

Biomarker analyses showed normalization of 186 genes linked to fibrosis and Crohn’s disease strictures, supporting translational potential in fibrostenotic Crohn’s disease (FSCD) ...

The FDA is forcing medical marketers to rethink every facet of campaigns and making campaign planning even more of a headache than it usually is.

Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs) - a particularly ...

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the potential of tumor necrosis factor-like ligand 1A ...

The National Association of Specialty Pharmacy (NASP) recognized outstanding poster presentations and awarded five Ron ...

Dave Canales benched Bryce Young two games into the 2024 season for ineffectiveness following a flurry of turnovers resulting in Carolina losing its first two games by a combined margin ...